OBJECTIVE: Cross-sectional studies suggest that lipopolysaccharide-binding protein (LBP) may be associated with obesity and metabolic disorders. However, prospective studies examining LBP are lacking. This prospective study investigated the association between LBP and metabolic abnormalities in 580 African ancestry men (mean age, 59.1 ± 10.5 years). RESEARCH DESIGN AND METHODS: We measured fasting serum LBP at baseline. Changes in adiposity and glucose homeostasis as well as case subjects with new type 2 diabetes and impaired fasting glucose (IFG) were assessed at a follow-up visit ~6 years later. Baseline LBP values were tested across quartiles for linear trend with metabolic measures. Multivariable logistic regression was used to determine the odds of new cases of IFG or diabetes per 1-SD greater baseline LBP. RESULTS: LBP was significantly associated with baseline BMI, waist circumference, whole-body and trunk fat, skeletal muscle density, fasting serum insulin, and HOMA-insulin resistance (IR) (all P < 0.01). Greater baseline LBP was significantly associated with longitudinal increases in the percentage of trunk fat (P = 0.025) and HOMA-IR (P = 0.034), but only borderline so with a decrease in skeletal muscle density (P = 0.057). In men with normal glucose, baseline LBP was associated with increased odds of having IFG at follow-up after adjustment for age, baseline trunk fat, and lifestyle factors (odds ratio per 1-SD LBP: 1.51; 95% CI 1.02-2.21). This association was attenuated after additional adjustment for change in trunk fat (P = 0.067). CONCLUSIONS: LBP may be a marker of prediabetes. Some of this association appears to be mediated through increased central and ectopic skeletal muscle adiposity.
OBJECTIVE: Cross-sectional studies suggest that lipopolysaccharide-binding protein (LBP) may be associated with obesity and metabolic disorders. However, prospective studies examining LBP are lacking. This prospective study investigated the association between LBP and metabolic abnormalities in 580 African ancestry men (mean age, 59.1 ± 10.5 years). RESEARCH DESIGN AND METHODS: We measured fasting serum LBP at baseline. Changes in adiposity and glucose homeostasis as well as case subjects with new type 2 diabetes and impaired fasting glucose (IFG) were assessed at a follow-up visit ~6 years later. Baseline LBP values were tested across quartiles for linear trend with metabolic measures. Multivariable logistic regression was used to determine the odds of new cases of IFG or diabetes per 1-SD greater baseline LBP. RESULTS:LBP was significantly associated with baseline BMI, waist circumference, whole-body and trunk fat, skeletal muscle density, fasting serum insulin, and HOMA-insulin resistance (IR) (all P < 0.01). Greater baseline LBP was significantly associated with longitudinal increases in the percentage of trunk fat (P = 0.025) and HOMA-IR (P = 0.034), but only borderline so with a decrease in skeletal muscle density (P = 0.057). In men with normal glucose, baseline LBP was associated with increased odds of having IFG at follow-up after adjustment for age, baseline trunk fat, and lifestyle factors (odds ratio per 1-SD LBP: 1.51; 95% CI 1.02-2.21). This association was attenuated after additional adjustment for change in trunk fat (P = 0.067). CONCLUSIONS:LBP may be a marker of prediabetes. Some of this association appears to be mediated through increased central and ectopic skeletal muscle adiposity.
Authors: E Bonora; G Targher; M Alberiche; R C Bonadonna; F Saggiani; M B Zenere; T Monauni; M Muggeo Journal: Diabetes Care Date: 2000-01 Impact factor: 19.112
Authors: Marta Serrano; José María Moreno-Navarrete; Josep Puig; María Moreno; Ester Guerra; Francisco Ortega; Gemma Xifra; Wifredo Ricart; José Manuel Fernández-Real Journal: Atherosclerosis Date: 2013-07-18 Impact factor: 5.162
Authors: José María Moreno-Navarrete; Xavier Escoté; Francisco Ortega; Matteo Serino; Mark Campbell; Marie-Caroline Michalski; Martine Laville; Gemma Xifra; Elodie Luche; Pere Domingo; Mónica Sabater; Gerard Pardo; Aurelie Waget; Javier Salvador; Marta Giralt; Jose I Rodriguez-Hermosa; Marta Camps; Catherine I Kolditz; Nathalie Viguerie; Jean Galitzky; Pauline Decaunes; Wifredo Ricart; Gema Frühbeck; Francesc Villarroya; Geltrude Mingrone; Dominique Langin; Antonio Zorzano; Hubert Vidal; Joan Vendrell; Remy Burcelin; Antonio Vidal-Puig; José Manuel Fernández-Real Journal: Diabetologia Date: 2013-08-21 Impact factor: 10.122
Authors: Sara M Reyna; Sangeeta Ghosh; Puntip Tantiwong; C S Reddy Meka; Phyllis Eagan; Christopher P Jenkinson; Eugenio Cersosimo; Ralph A Defronzo; Dawn K Coletta; Apiradee Sriwijitkamol; Nicolas Musi Journal: Diabetes Date: 2008-07-15 Impact factor: 9.461
Authors: J M Moreno-Navarrete; G Blasco; J Puig; C Biarnés; M Rivero; J Gich; F Fernández-Aranda; J Garre-Olmo; L Ramió-Torrentà; Á Alberich-Bayarri; F García-Castro; S Pedraza; W Ricart; J M Fernández-Real Journal: Int J Obes (Lond) Date: 2017-07-07 Impact factor: 5.095
Authors: Abigail J S Armstrong; Kevin Quinn; Jennifer Fouquier; Sam X Li; Jennifer M Schneider; Nichole M Nusbacher; Katrina A Doenges; Suzanne Fiorillo; Tyson J Marden; Janine Higgins; Nichole Reisdorph; Thomas B Campbell; Brent E Palmer; Catherine A Lozupone Journal: mSystems Date: 2021-05-18 Impact factor: 6.496
Authors: Elena Barengolts; Stefan J Green; George E Chlipala; Brian T Layden; Yuval Eisenberg; Medha Priyadarshini; Lara R Dugas Journal: Microorganisms Date: 2019-09-05